Drug Formulary

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Find more safety information in the supplementary patient handouts:

Download how to Safely Take Your Oral Anti-Cancer Medication

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Funded Evidence-informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

For patient information about regimens that include both chemotherapy and immunotherapy, download Treating cancer with chemotherapy and immunotherapy: What you need to know.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

What's New - Drugs

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Filters

Global Date

Showing 4 of 4 results

drug

abiraterone

NEW Jul 2026

Global Date:: {"date":"11 07 2026"}
Revision Summary:: Updated abiraterone funding (ODB general benefit) and Dosing section
Cancer Type:: Genitourinary, Prostate, Adrenal
Search:: abiraterone

Quick Link(s):

Drug Monograph , Patient Info Sheet

drug

anagrelide

NEW Jul 2026

Global Date:: {"date":"20 07 2026"}
Revision Summary:: Drug Monograph: bug 1080418 2nd retest - 0720 - DM
Patient Info Sheet EN: bug 1080418 2nd retest - 0720 - MIS
Cancer Type:: Hematologic, Myeloproliferative Neoplasms (MPNs)
Search:: anagrelide

Quick Link(s):

Drug Monograph , Patient Info Sheet

drug

cyclophosphamide

NEW Jul 2026

Global Date:: {"date":"08 07 2026"}
Revision Summary:: Drug Monograph: DM-0708
Patient Info Sheet: MIS eng-0708
Cancer Type:: Breast, Sarcoma, Ewing's, Soft Tissue, Gynecologic, Gestational Trophoblastic Disease, Hematologic, Leukemia - Chronic Lymphocytic (CLL), Lung, Thymoma, Lymphoma - Non-Hodgkin's Low Grade, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade, Multiple Myeloma, Lymphoma - Hodgkin, Small Cell, Gastrointestinal, Colorectal, Cervix, Endometrial, Ovary, Gastric Stomach, Esophagus, Hepatobiliary Liver Bile Duct, Pancreas, Genitourinary, Prostate, Bladder Urothelial, Endocrine, Adrenal, Lymphoma - T-cell, Head and Neck, Leukemia - Acute Lymphoblastic (ALL), Wilm's Tumour, Neuroendocrine (GI), Rare Diseases, Amyloidosis
Search:: cyclophosphamide

Quick Link(s):

Drug Monograph , Patient Info Sheet

drug

vanDETanib

NEW Jul 2026

Global Date:: {"date":"07 07 2026"}
Revision Summary:: Patient Info Sheet: MIS eng- retrieve 0707
Cancer Type:: Endocrine, Thyroid
Search:: vanDETanib

Quick Link(s):

Drug Monograph , Patient Info Sheet

/ 1

What's New - Regimens

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Filters

Sort By

Global Date

Intent

Funding Program

Showing 10 of 11 results

regimen

ABVD

NEW Jul 2026

Cancer Type:: Hematologic, Lymphoma - Hodgkin
Intent:: Curative
Drugs Used:: DOXOrubicin , bleomycin , vinBLAStine , dacarbazine
Revision Summary:: Regimen Monograph: RM publish 0707Patient Info Sheet EN: RIS- no publish title- eng - 0707Patient Info Sheet EN: (abvd english-0707) - RIS - eng-publish 0707Patient Info Sheet EN: (ABVD10) - ABVD (Lymphoma)- eng 10 -0709Patient Info Sheet EN: (ABVD11) - ABVD (Lymphoma)- eng 11 -0709Patient Info Sheet EN: (ABVD12) - ABVD (Lymphoma)- eng 12 -0709Patient Info Sheet EN: (ABVD13) - ABVD (Lymphoma)- eng 13 -0709Patient Info Sheet EN: (ABVD14) - ABVD (Lymphoma)- eng 14 -0709Patient Info Sheet EN: (ABVD15) - ABVD (Lymphoma)- eng 15 -0709Patient Info Sheet EN: (ABVD16) - ABVD (Lymphoma)- eng 16 -0709Patient Info Sheet EN: (ABVD17) - ABVD (Lymphoma)- eng 17 -0710Patient Info Sheet EN: (ABVD18) - ABVD (Lymphoma)- eng 18 -0710Patient Info Sheet EN: (ABVD19) - ABVD (Lymphoma)- eng 19 -0710Patient Info Sheet EN: (ABVD20) - ABVD (Lymphoma)- eng 20 -0710Patient Info Sheet EN: (ABVD21) - ABVD (Lymphoma)- eng 21 -0716Patient Info Sheet EN: (ABVD4) - ABVD (Lymphoma)- eng 4 -0709Patient Info Sheet EN: (ABVD5) - ABVD (Lymphoma)- eng 5 -0709Patient Info Sheet EN: (ABVD6) - ABVD (Lymphoma)- eng 6 -0709Patient Info Sheet EN: (ABVD7) - ABVD (Lymphoma)- eng 7 -0709Patient Info Sheet EN: (ABVD8) - ABVD (Lymphoma)- eng 8 -0709Patient Info Sheet EN: (ABVD9) - ABVD (Lymphoma)- eng 9 -0709
Global Date:: {"date":"07 07 2026"}
Search:: ABVD

Quick Link(s):

Regimen Monograph

regimen

ANGR

NEW Jul 2026

Cancer Type:: Hematologic, Myeloproliferative Neoplasms (MPNs)
Intent:: Palliative
Funding Program:: ODB Limited Use
Drugs Used:: anagrelide
Revision Summary:: Regimen Monograph: defect 1080418
Global Date:: {"date":"17 07 2026"}
Search:: ANGR

Quick Link(s):

Regimen Monograph

regimen

BEND+RITU

NEW Jul 2026

Cancer Type:: Hematologic, Lymphoma - Non-Hodgkin's Low Grade
Intent:: Palliative
Funding Program:: New Drug Funding Program
Drugs Used:: riTUXimab , bendamustine , riTUXimab (subcut)
Revision Summary:: Patient Info Sheet EN: RIS- eng publish 0707 testing unhide
Global Date:: {"date":"31 03 2026"}
Search:: BEND+RITU

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Breast
Intent:: Palliative
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Breast
Intent:: Adjuvant
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Gastrointestinal, Pancreas
Intent:: Palliative
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Unknown Primary
Intent:: Palliative
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Gastrointestinal, Colorectal, Small bowel and appendix
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

CAPE

NEW Jul 2026

Cancer Type:: Head and Neck
Intent:: Palliative
Funding Program:: ODB - General Benefit
Drugs Used:: capecitabine
Revision Summary:: Patient Info Sheet EN: publish 0710- RIS eng
Global Date:: {"date":"23 07 2024"}
Search:: CAPE

Quick Link(s):

Regimen Monograph

regimen

GLOF; GLOF(RAMP)

NEW Jul 2026

Cancer Type:: Hematologic, Lymphoma - Non-Hodgkin's High Grade, Lymphoma - Non-Hodgkin's Intermediate Grade
Intent:: Palliative
Funding Program:: New Drug Funding Program High Cost Therapy Funding Program
Drugs Used:: oBINutuzumab , glofitamab
Revision Summary:: Regimen Monograph: Updated Supportive Care and Adverse effects sections-0708Patient Info Sheet EN: (1-RIS) - RIS eng - RM 2 regimen codes -0708
Global Date:: {"date":"08 07 2026"}
Search:: GLOF; GLOF(RAMP)

Quick Link(s):

Regimen Monograph

regimen

VIP

NEW Jul 2026

Cancer Type:: Genitourinary, Testis
Intent:: Curative
Drugs Used:: etoposide , CISplatin , mesna , ifosfamide
Revision Summary:: Patient Info Sheet EN: retrieve-ris eng -1
Global Date:: {"date":"08 07 2026"}
Search:: VIP

Quick Link(s):

Regimen Monograph

/ 2

Last Updated: July 27, 2026

The information on this website is intended for informational purposes only and is not a substitute for medical advice. Always consult your health care provider if you have questions or concerns. The use of the information on this website does not create a physician-patient relationship between Ontario Health and you.
Ontario Health is committed to ensuring accessible services and communications to individuals with disabilities. To receive any information on this website in an alternate format, please contact Ontario Health’s Communications Department at: 1-877-280-8538,TTY 1-800-855-0511, or by email at info@ontariohealth.ca.

Drug Formulary

Drugs

Displaying Results

Filters

Filters

Name

Trade Name

Other Names

Cancer Type

Global Date

abemaciclib

abiraterone

acalabrutinib

AFAtinib

aflibercept

aldesleukin

alectinib

alemtuzumab

alpelisib

amivantamab

amsacrine

anagrelide

anastrozole

apalutamide

aprepitant / fosaprepitant

arsenic trioxide

asciminib

atezolizumab

atezolizumab (subcut)

avelumab

aXitinib

azaCITIDine

azaCITIDine (tablets)

BCG

belzutifan

bendamustine

bevacizumab

bicalutamide

binimetinib

bleomycin

blinatumomab

bortezomib

bosutinib

brentuximab vedotin

brigatinib

buserelin

busulfan

cabazitaxel

cabozantinib (tablet)

calaspargase pegol

capecitabine

capivasertib

CARBOplatin

carfilzomib

carmustine

cemiplimab

ceritinib

cetuximab

chlorambucil

CISplatin

cladribine

clodronate

cobimetinib

crisantaspase recombinant

crizotinib

cyclophosphamide

cyproterone

cytarabine

daBRAFenib

dacarbazine

dacomitinib

DACTINomycin

daratumumab

daratumumab (subcut)

darbepoetin

darolutamide

daSATinib

DAUNOrubicin

decitabine / cedazuridine

degarelix